UNLABELLED: Pulmonary uptake of (18)F-FDG assessed with PET has been used to quantify the metabolic activity of inflammatory cells in the lung. This assessment involves modeling of tracer kinetics and knowledge of a time-activity curve in pulmonary artery plasma as an input function, usually acquired by manual blood sampling. This paper presents and validates a method to accurately derive an input function from a blood-pool region of interest (ROI) defined in dynamic PET images. METHODS: The method is based on a 2-parameter model describing the activity of blood and that from spillover into the time-activity curve for the ROI. The model parameters are determined using an iterative algorithm, with 2 blood samples used to calibrate the raw PET-derived activity data. We validated both the 2-parameter model and the method to derive a quantitative input function from ROIs defined for the cavities of the right and left heart and for the descending aorta by comparing them against the time-activity curve obtained by manual blood sampling from the pulmonary artery in lungs with acute inflammation. RESULTS: The model accurately described the time-activity curve from sampled blood. The 2-sample calibration method provided an efficient algorithm to derive input functions that were virtually identical to those sampled manually, including the fast kinetics of the early phase. The (18)F-FDG uptake rates in acutely injured lungs obtained using this method correlated well with those obtained exclusively using manual blood sampling (R(2) > 0.993). Within some bounds, the model was found quite insensitive to the timing of calibration blood samples or the exact definition of the blood-pool ROIs. CONCLUSION: Using 2 mixed venous blood samples, the method accurately assesses the entire time course of the pulmonary (18)F-FDG input function and does not require the precise geometry of a specific blood-pool ROI or a population-based input function. This method may substantially facilitate studies involving modeling of pulmonary (18)F-FDG in patients with viral or bacterial infections, pulmonary fibrosis, and chronic obstructive pulmonary disease.
UNLABELLED: Pulmonary uptake of (18)F-FDG assessed with PET has been used to quantify the metabolic activity of inflammatory cells in the lung. This assessment involves modeling of tracer kinetics and knowledge of a time-activity curve in pulmonary artery plasma as an input function, usually acquired by manual blood sampling. This paper presents and validates a method to accurately derive an input function from a blood-pool region of interest (ROI) defined in dynamic PET images. METHODS: The method is based on a 2-parameter model describing the activity of blood and that from spillover into the time-activity curve for the ROI. The model parameters are determined using an iterative algorithm, with 2 blood samples used to calibrate the raw PET-derived activity data. We validated both the 2-parameter model and the method to derive a quantitative input function from ROIs defined for the cavities of the right and left heart and for the descending aorta by comparing them against the time-activity curve obtained by manual blood sampling from the pulmonary artery in lungs with acute inflammation. RESULTS: The model accurately described the time-activity curve from sampled blood. The 2-sample calibration method provided an efficient algorithm to derive input functions that were virtually identical to those sampled manually, including the fast kinetics of the early phase. The (18)F-FDG uptake rates in acutely injured lungs obtained using this method correlated well with those obtained exclusively using manual blood sampling (R(2) > 0.993). Within some bounds, the model was found quite insensitive to the timing of calibration blood samples or the exact definition of the blood-pool ROIs. CONCLUSION: Using 2 mixed venous blood samples, the method accurately assesses the entire time course of the pulmonary (18)F-FDG input function and does not require the precise geometry of a specific blood-pool ROI or a population-based input function. This method may substantially facilitate studies involving modeling of pulmonary (18)F-FDG in patients with viral or bacterial infections, pulmonary fibrosis, and chronic obstructive pulmonary disease.
Authors: L Sokoloff; M Reivich; C Kennedy; M H Des Rosiers; C S Patlak; K D Pettigrew; O Sakurada; M Shinohara Journal: J Neurochem Date: 1977-05 Impact factor: 5.372
Authors: Senthil K Sundaram; Nanette M T Freedman; Jorge A Carrasquillo; Joann M Carson; Millie Whatley; Steven K Libutti; David Sellers; Stephen L Bacharach Journal: J Nucl Med Date: 2004-08 Impact factor: 10.057
Authors: Marcos F Vidal Melo; Dominick Layfield; R Scott Harris; Kevin O'Neill; Guido Musch; Torsten Richter; Tilo Winkler; Alan J Fischman; Jose G Venegas Journal: J Nucl Med Date: 2003-12 Impact factor: 10.057
Authors: Tyler J Wellman; Tilo Winkler; Eduardo L V Costa; Guido Musch; R Scott Harris; Hui Zheng; Jose G Venegas; Marcos F Vidal Melo Journal: Crit Care Med Date: 2014-07 Impact factor: 7.598
Authors: Guido Musch; Tilo Winkler; R Scott Harris; Marcos F Vidal Melo; Tyler J Wellman; Nicolas de Prost; Richard L Kradin; Jose G Venegas Journal: Anesthesiology Date: 2014-03 Impact factor: 7.892
Authors: Eduardo L V Costa; Guido Musch; Tilo Winkler; Tobias Schroeder; R Scott Harris; Hazel A Jones; Jose G Venegas; Marcos F Vidal Melo Journal: Anesthesiology Date: 2010-03 Impact factor: 7.892
Authors: Nicolas de Prost; Eduardo L Costa; Tyler Wellman; Guido Musch; Tilo Winkler; Mauro R Tucci; R Scott Harris; Jose G Venegas; Marcos F Vidal Melo Journal: J Appl Physiol (1985) Date: 2011-07-28
Authors: Tyler J Wellman; Nicolas de Prost; Mauro Tucci; Tilo Winkler; Rebecca M Baron; Piotr Filipczak; Benjamin Raby; Jen-Hwa Chu; R Scott Harris; Guido Musch; Luiz F Dos Reis Falcao; Vera Capelozzi; Jose G Venegas; Marcos F Vidal Melo Journal: Anesthesiology Date: 2016-11 Impact factor: 7.892
Authors: Tobias Schroeder; Marcos F Vidal Melo; Guido Musch; R Scott Harris; Jose G Venegas; Tilo Winkler Journal: Acad Radiol Date: 2008-06 Impact factor: 3.173